Abstract 2143: Anti-TGFβ antibody treatment rescues doxorubicin- mediated bone loss in preclinical osteolytic breast cancer metastasis models.
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 20
(3-4)
◽
pp. 103-108
◽
Keyword(s):
Keyword(s):